Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × marizomib × Clear all

Phase

Phase 1 4 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 252 Cisplatin 242 Radiotherapy 218 Paclitaxel 207 Docetaxel 194 Fluorouracil 190 Carboplatin 187 Doxorubicin 186 Dexamethasone 145 Gemcitabine 130 Vincristine 122 Capecitabine 112 Prednisone 109 Etoposide 109 Leucovorin 106 Bevacizumab 101 Methotrexate 100 Rituximab 95 Cytarabine 93 Filgrastim 82 Trastuzumab 81 Oxaliplatin 75 pembrolizumab 66 Pemetrexed 60 Drug Therapy 60 Tamoxifen 59 Epirubicin 55 Chemotherapy, Adjuvant 52 Irinotecan 51 Granulocyte Colony-Stimulating Factor 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03345095 2025-07-01

MIRAGE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed

749 enrolled 15 charts

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡